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Abstract
Liquid-filled perfluorocarbon droplets emit a unique acoustic signature when vaporized into to 
gas-filled microbubbles using ultrasound. Here, we conducted a pilot study in a tissue-mimicking 
flow phantom to explore the spatial aspects of droplet vaporization and investigate the effects of 
applied pressure and droplet concentration on image contrast and axial and lateral resolution. 
Control microbubble contrast agents were used for comparison. A confocal dual-frequency 
transducer was used to transmit at 8 MHz and passively receive at 1 MHz. Droplet signals were of 
significantly higher energy than microbubble signals. This resulted in improved signal separation 
and high contrast-to-tissue ratios (CTR). Specifically, with a peak negative pressure (PNP) of 450 
kPa applied at the focus, the CTR of B-mode images was 18.3 dB for droplets and −0.4 for 
microbubbles. The lateral resolution was dictated by the size of the droplet activation area, with 
lower pressures resulting in smaller activation areas and improved lateral resolution (0.67 mm at 
450 kPa). The axial resolution in droplet images was dictated by the size of the initial droplet and 
independent of the properties of the transmit pulse (3.86 mm at 450 kPa). In post-processing, time-
domain averaging (TDA) improved droplet and microbubble signal separation at high pressures 
(640 kPa and 700 kPa). Taken together, these results indicate that it is possible to generate high-
sensitivity, high-contrast images of vaporization events. In the future, this has the potential to be 
applied in combination with droplet-mediated therapy to track treatment outcomes or as a stand-
alone diagnostic system to monitor the physical properties of the surrounding environment.
Index Terms
acoustic droplet vaporization; phase change contrast agent; contrast enhanced ultrasound; tissue 
characterization; nanodroplet; nanoemulsions; perfluorocarbon
I. Introduction
Ultrasound is a widely used imaging modality primarily due to its ability to capture images 
in real-time without exposing the interrogated tissue to ionizing radiation. Additionally, 
ultrasound systems are relatively low cost and portable, making them useful in a variety of 
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from tissue components. Therefore, anatomical features exhibiting poor scattering cannot 
readily be detected. For example, perfusion differences that exist between diseased and 
normal tissues, such as in the case of a highly vascularized tumor, cannot be quantified with 
standard brightness mode (B-mode) imaging, because blood is a poor scatterer.
To image the vasculature, the acoustic properties of blood can be modified by injecting 
microbubble contrast agents [1]. These particles typically consist of a gas core encapsulated 
by an albumin, galactose, polymer, or lipid shell [2]. Introducing a gaseous component into 
the blood enhances its echogenicity. When insonified, microbubbles oscillate in a non-linear 
manner and may generate second harmonic [3], super-harmonic [4], and sub-harmonic [5] 
frequency components. This has given rise to many bubble-specific imaging strategies, 
including pulse inversion [6], amplitude modulation [7], cadence imaging (combination of 
pulse inversion and amplitude modulation) [8], chirp reversal [9], and dual-frequency 
superharmonic imaging [10, 11].
Despite the significant advancements in ultrasonic imaging afforded by the use of 
microbubbles, size and circulation limitations restrict their application space to short-lived 
studies within the vascular compartment. Specifically, microbubbles are too large (1–10 µm 
diameter [12]) for extravasation through cell-to-cell junctions (0.1–0.8 µm spacing in 
diseased tissue [13]). This prevents the interrogation of extravascular molecular markers or 
accumulation via the enhanced permeability and retention effect in tumors. A short 
circulation half-life (1–10 min [12]) precludes the application of microbubbles in long-
duration studies, where it is desirable to perform contrast enhanced imaging or therapy 
mediated by the contrast agent for up to 1 hr without re-dosing. Examples may include using 
microbubbles to monitor coagulation necrosis during radiofrequency ablation [14] or 
microbubble-mediated blood-brain-barrier barrier disruption of large volumes greater than 
1cm3 [15].
To permeate tumor tissue and/or improve circulation time, researchers have been exploring 
the use of liquid-filled droplets that undergo a phase change to gas-filled microbubbles when 
subject to a sufficient negative pressure, a process referred to as acoustic droplet 
vaporization. These phase change contrast agents can be produced with microscale 
diameters (3–6 µm [16]) for intravascular applications or nanoscale diameters (200–600 nm 
[17]) for extravascular applications. While in the liquid state, certain droplet formulations 
have been shown to remain stable in vivo for at least 96 min [18]. Once insonified and 
transitioned into microbubbles, they exhibit sufficient scattering cross-section to yield 
measureable levels of contrast [19, 20]. The recent development of a new method for 
condensing microbubbles into droplets has simplified the fabrication process [21, 22]. 
Additionally, it permits the use of volatile, low-boiling point perfluorocarbons as the core 
material, which allows for vaporization of sub-micron agents with pressures that are safe for 
diagnostic imaging [23].
The majority of studies on droplets have focused on therapeutic applications, such as vessel 
occlusion [16, 24, 25], drug delivery [26–28], and enhancement of thermal [29–31] and non-
thermal [32] ablation. The rapid expansion in volume during the vaporization process (5–10 
times the original diameter in an un-degassed environment [17]) along with the 
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spatiotemporal control of vaporization using focused pulses can be tuned to produce the 
desired bioeffect. There is also a growing level of interest in using droplets for diagnostic 
applications. To date, studies have been conducted on phase aberration correction [25], 
wash-out characterization of kidney imaging [33], intravascular molecular imaging by 
targeting alpha(v)-integrins [34], and extravascular imaging through passive accumulation in 
tumors [20]. All of these techniques are designed to image the microbubbles generated from 
activated droplets using conventional B-mode or microbubble specific imaging techniques. 
However, there may be information contained within the vaporization event itself that, if 
captured, could enable new diagnostic applications or methods of monitoring therapeutic 
outcomes.
Using high-speed video microscopy, Sheeran et al. found that activated droplets initially 
over-expand and then settle to a final microbubble resting diameter in a oscillatory manner 
[35]. Additionally, by using a ‘pulse-high’ (8 MHz) ‘listen-low’ (1 MHz) methodology to 
isolate vaporization signals, it was determined that this process produces a unique acoustic 
signature resembling an exponentially decaying sinusoidal signal. The amplitude of the 
sinusoidal signal is greater for larger droplets, as they displace more fluid upon activation. 
Further, the frequency of the signal is dictated by the final microbubble diameter, with 
smaller bubbles oscillating at higher frequencies according to equations for a damped 
harmonic oscillator undergoing un-forced oscillation [36]. Therefore, it may be possible to 
detect physical properties of both the encapsulating shell and the surrounding environment 
(such as ambient pressure, temperature, and viscosity), that manifest as alterations in bubble 
oscillation.
Here, we utilize the ‘pulse-high, listen-low’ strategy employed by Sheeran et al. [35] to 
develop an imaging system for capturing droplet vaporization events and generating 
ultrasound images. We explore the spatial aspects of vaporization and determine the inherent 
trade-offs between the applied pressure and image resolution. Droplets and microbubbles are 
imaged inside a microcellulose tube embedded within a tissue-mimicking phantom to study 
the effects of attenuation. This represents an extension of our previous feasibility study, 
which constructed images of a tube in a water bath [37].
The results presented herein indicate that high-contrast images can be created from 
vaporization signals inside a tissue phantom. The lateral resolution decreases with increasing 
applied pressure. This is due to the fact that the droplet activation area limits the lateral 
resolution, and the activation area increases with increasing pressure. The axial resolution is 
dictated by the exponential decay rate in the vaporization signal. Additionally, post-
processing techniques such as time-domain averaging (TDA) and energy detection were able 
to improve the separation of vaporization signals from signals corresponding to control 
microbubbles oscillation.
II. Methods
A. Microbubble and Droplet Fabrication
Microbubbles were generated with a lipid shell encapsulating an octafluoropropane (OFP; 
boiling point −36.7 °C) gas core, as previously described [38]. This formulation is similar to 
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that of DEFINITY®, which has been FDA approved for echocardiography in that it involves 
a high molecular weight perfluorocarbon and lipid shell. Briefly, a 9:1 M dissolution of 1,2-
distearoyl-sn-glycero-3-phosphocholine (DSPC) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-methoxy (polyethylene-glycol)-2000 (DSPE-PEG2000) was 
formed in a 16:3:1 excipient solution of phosphate-buffered saline (PBS), propylene glycol, 
and glycerol for a total lipid concentration of 1 mg/ml. Lipids were purchased from Avanti 
Polar Lipids (Alabaster, AL, USA). 1.5 ml of the lipid solution was aliquoted into 3 ml glass 
vials and gas exchanged with OFP (FluoroMed, Round Rock, TX, USA) to replace the free 
and dissolved air. To generate microbubbles, vials were mechanically agitated (Vialmix, 
Bristol-Myers Squibb, New York, NY, USA) for 45 s, which resulted in a polydisperse 
distribution. These microbubbles were used in control experiments.
To form droplets, microbubbles were condensed into droplets according to established 
techniques [38]. Following mechanical agitation, the vials were submerged in an isopropanol 
bath maintained at approximately −10 °C and swirled gently for 2 min. While remaining in 
the bath, the vials were connected to an adjustable air-pressure source, and the headspace 
pressure was increased to ensure that the majority of the microbubbles visibly converted to 
droplets. This required pressures on the order of 50 psi. Vials were then stored for no more 
than 30 min at 4 °C prior to use.
B. Microbubble and Droplet Characterization
Droplets were characterized using a NanoSight NS500 (Malvern Instruments Inc., 
Westborough, MA, USA). Samples were diluted 1:200 in PBS. Six, 30 s recordings were 
captured from each vial at 23.3°C with a viscosity of 0.924 cP and detection threshold of 9. 
The six concentration and size measurements from each vial were averaged to form one 
representative sample, and the entire process was repeated for a total of 3 vials. Then, the 
measurements from each vial were averaged together. The averaged distribution of droplets 
had a mean diameter of 157 ± 9 nm, mode size of 111 ± 10 nm, and total concentration of 
2.38×1011 ± 1.07×1011 particles/ml. Reproducibility between vials was high for the mean 
and modal diameter. The NanoSight was unable to detect content larger than ~500 nm, 
because the measurements were dominated by the peak at 111 nm.
An AccuSizer 780A (Particle Sizing Systems, Port Richey, FL, USA) capable of measuring 
particles ranging in size from 0.5 to 500 µm, was used to observe larger droplet content, and 
to characterize microbubbles. For microbubbles, 2 µl of the sample was injected into 50 ml 
of deionized water in the dilution flask. For droplets, a larger volume of 50 µl was required 
to compensate for the fact that most of the particles were submicron in size. Three trials 
were performed per vial, and the statistics were averaged to form one representative sample. 
Then, the measurements from three separate vials were averaged together. The averaged 
distribution of droplets had a mean diameter of 0.98 ± 0.10 µm, mode size of 0.58 ± 0.01 
µm, and total concentration of 2.77×108 ± 3.04×106 particles/ml. The concentration of larger 
droplet content observed by the AccuSizer was approximately three orders of magnitude 
smaller than that of content less than 0.5 µm observed by the NanoSight. The averaged 
distribution of control microbubbles had a mean diameter of 1.02 ± 0.03 µm, mode size of 
0.59 ± 0.01 µm, and total concentration of 1.11×1010 ± 3.32×109 particles/ml.
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C. Experimental Setup and Phantom Creation
A dual-frequency transducer design was utilized that consisted of two confocal piston 
transducers (Fig. 1). The inner element was used to transmit a 2 cycle, high-frequency (8 
MHz) Gaussian enveloped sinusoid (7.5 MHz center frequency, 1.27 cm diameter, 5.08 cm 
focus; V320, Panametrics Inc., Waltham, MA, USA). The outer element was used to 
passively receive at low-frequency (1 MHz center frequency, 3.81 cm diameter, 5.08 cm 
focus; V30047, Panametrics Inc., Waltham, MA, USA). Transmit pulses were applied at a 
repetition rate of 10 Hz with excitation signals from an arbitrary function generator (AFG 
3101, Tektronix, Beaverton, OR, USA) that were amplified with a 60 dB power amplifier 
(A-500, ENI, Rochester, NY, USA). Transducer calibration was performed in the free-field 
at the focus using a needle hydrophone (HNA-0400, Onda Corp., Sunnyvale, CA, USA) to 
obtain pressure output information. Received signals were filtered (0.1 MHz to 3 MHz band-
pass) and amplified (32 dB) using a broadband receiver (BR-640A, RITEC Inc., Warwick, 
RI, USA). Then, A/D conversion was performed at a 100 MHz sampling rate using a 14-Bit 
waveform digitizer (PDA14, Signatec, Lockport, IL, USA) controlled by LabVIEW 
(National Instruments, Austin, TX, USA).
The tissue-mimicking phantom tested in this study was constructed by embedding a 
microcellulose tube (~220 µm inner diameter) inside a gellan gum base material. The tube 
was included to simulate a micro blood vessel, through which contrast agent could be 
infused. The base material was similar to that described in [39], which was originally 
developed for high-intensity focused ultrasound, except that graphite powder (13.5 g) was 
used as the scattering medium in lieu of aluminum oxide particles (6.75 g in the original 
recipe). The other components of the recipe (gellan gum, calcium chloride, potassium 
sorbate, and propanol) remained the same. Following mixing of the components and while 
in the liquid state (70°C), the phantom was poured into a mold containing the microcellulose 
tube and allowed to solidify during the cooling process.
Attenuation coefficients of the phantom were measured by the through-transmission 
substitution technique [40] for eight discrete frequencies (from 1 to 8 MHz). Acoustical 
measurements were performed before and after insertion of the phantom in a degassed-water 
tank maintained at 37°C. Ultrasound waves were generated from three different focused 
single-element transducers (V30047, V382, V320, Panametrics Inc., Waltham, MA) focused 
at 50 mm and centered at 1 MHz, 3.5 MHz and 7.5 MHz to cover the full range of 
frequencies. Transducers were driven with the same arbitrary function generator and 
amplifier arrangement as previously described. For each frequency, a 10-cycle excitation 
tone burst was transmitted at a peak negative pressure (PNP) less than 160 kPa at the focus 
to avoid undesirable nonlinear propagation. The delivered excitation pulses were measured 
using the needle hydrophone placed at the focal distance of the transducers. The pulses 
received by the hydrophone were captured with the A/D converter, and data was transferred 
to MATLAB (R2013b, The Mathworks, Natick, MA, USA) for offline analysis. Both the 
hydrophone and transducers were mounted on a holder to be static during the experiment. 
For attenuation measurements (Table I), the phantom was positioned in front of the 
transducer as closely as possible to the hydrophone. The attenuation coefficient (dB per unit 
length) at frequency, f was given by the equation:
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where d is the phantom thickness, and E0 and E are the energy of the signal propagated in 
water and through the phantom, respectively. The ultrasound attenuation exhibits a 
frequency dependent relationship as:
(2)
where A = 0.24 ± 0.02 dB.cm−1.MHz−1 and n = 1.46. The attenuation coefficient of the 
phantom was on the same order of magnitude as typical attenuation values measured for 
blood (0.09–0.17 dB.cm−1.MHz−1) and fatty tissue (0.38–0.78 dB.cm−1.MHz−1) [41].
D. Data Acquisition and Image Processing
The stand-alone microcellulose tube and tissue phantom were placed in heated (37°C) 
degassed water at the transducer focus. The stock solutions of microbubbles and droplets 
were diluted in PBS (0.03% and 0.3% v/v) and continuously infused through the tube at 50 
µl/min using a syringe pump (PHD2000, Harvard Apparatus, Holliston, MA, USA) to ensure 
that the activated volume did not interfere with subsequent pulses. LabVIEW was used to 
raster the transducer in the elevational (4 mm, 121 µm step size) and lateral (3 mm, 125 µm 
step size) dimensions. At each location, five radiofrequency (RF) lines were acquired and 
stored for offline analysis. In the tissue phantom, the PNPs at the focus were 160, 450, 640, 
700, and 770 kPa (after accounting for attenuation).
Images were created from the stored RF data using a custom MATLAB script. A 3rd order 
Butterworth filter was applied to isolate vaporization signals (400 kHz to 1.6 MHz band-
pass). After filtering, two types of images were generated, including conventional B-mode 
images in the axial-lateral plane and energy projections (EPs) in the lateral-elevational plane. 
In the case of the B-mode images, the center slice through the tube was selected, and the 
highest intensity signal was selected out of the five received at each lateral position. Then, 
the envelope of the signal was taken (absolute value of the Hilbert transform), converted to a 
decibel scale, and plotted. In the case of the EPs, the energy was calculated as the 
summation of squared signals within a 12 µs window surrounding the five signals received at 
each lateral-elevational position. Then, the highest energy signal was selected as the 
representative pixel value at that position and projected onto the lateral-elevational plane. 
Energy was chosen as an initial method to separate vaporization events from control 
microbubble signals, because vaporization signals possess significantly higher energy at low 
mechanical index, as noted by their long tails (see Fig. 2a). In all images, pixel values were 
linearly interpolated on a refined grid formed by dividing the interval between pixels three 
times in each dimension.
The contrast-to-tissue ratio (CTR) was calculated in the B-mode and EP images. In the B-
mode images, the energy outside the tube was subtracted from the energy inside the tube, for 
each pixel row, and the results were averaged to obtain a single value. The energy was 
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calculated as the summation of squared signals within a 12 µs window at each lateral 
position. The window was centered around the tube to measure the signal from contrast 
agents, or located directly in front of the tube to measure tissue signals. In the EP images, 
the average pixel value outside the tube was subtracted from the average pixel value inside 
the tube, for each pixel column, as pixel values were already in units of energy. These results 
were then averaged to obtain a single value. The region outside the tube was located at the 
maximum elevational distance above the tube, and the region inside the tube was located 
around the central elevational slice. The specified regions of interest in B-mode and EP 
images are shown as red dotted lines in Figs. 3 and 4, respectively.
The axial resolution was calculated based on the enveloped and log compressed signals 
acquired during each trial. The signals were normalized to their maximum value, and the −6 
dB point from the peak was selected as the threshold pixel value for defining the distance 
associated with the axial resolution. Data exhibiting a poor signal-to-noise ratio (i.e., < 6dB) 
were not included in axial resolution calculations.
The tube width at −10 dB was calculated for each pixel column within an EP image, and the 
results were averaged to obtain a single value. Pixel values were interpolated with splines 
using ten query points per pixel. Additionally, RF lines that contained noisy signals or a −10 
dB point that fell within the baseline noise were excluded from calculations.
Time domain averaging (TDA) was investigated as a secondary method for improving the 
separation of droplet and microbubble signals in B-mode and EP images. The five RF lines 
received at each location were averaged, and then the average RF line was subtracted from 
each individual receive line prior to envelope detection and energy calculations. This 
technique has been studied as a way to reject clutter during color Doppler imaging [42], as 
signals that are relatively constant and appear in each receive line are removed. In the case of 
droplet activation, vaporization signals vary in amplitude, frequency, and phase to a greater 
extent than microbubble and tissue signals received at 1/8 the insonification frequency. This 
is due to the stochastic nature of droplet activation (i.e., not all transmit events induce 
vaporization, even when the PNP is above the threshold for activation) as well as the 
dependence of the vaporization signal on droplet size.
One-way ANOVA was used to investigate the effects of contrast agent formulation, 
concentration, and applied pressure on the axial resolution and apparent tube width. The 
analysis was performed on non-TDA datasets. In the event of a significant main effect, 
pairwise comparisons were completed using Tukey’s Honestly Significant Difference 
(HSD). A similar analysis was conducted for CTR calculations in B-mode and EP images, 
with and without TDA. All statistical analyses were conducted using Minitab Express 
(Minitab, State College, PA, USA) with a significance level of p < 0.05.
III. Results
Droplet activation resulted in exponentially decaying sinusoidal signals in the time-domain 
(Fig. 2a). The initial peak is caused by the rapid expansion in droplet diameter during 
vaporization, and the decaying oscillatory tail is caused by the oscillation of the generated 
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microbubbles around their final resting diameter [35]. The amplitude and length of the 
signals varied between events, even at constant pressure. Signals from control microbubbles 
were more consistent in amplitude within a given pressure group, and lacked the oscillatory 
tail feature. The frequency of the droplet signals also varied between events, and the 
spectrum was distinctly more narrowband compared to microbubble trials (Fig. 2b). 
Microbubbles excited by the 8 MHz transmit pulse return a wideband echo to the 1 MHz 
receive transducer that caused it to ring at its center frequency. Alternatively, peaks in 
droplet frequency correspond to the rate at which newly generated microbubbles oscillate 
around their final diameter. Over the course of the experiments, peaks in the droplet 
spectrum were observed primarily in the range of frequencies corresponding to the receiving 
transducer bandwidth, between 400 kHz and 1.6 MHz. The band-pass filter was used to 
isolate this frequency content.
B-mode images at 700 kPa are shown in Fig. 3. The oscillatory behavior of activated 
droplets resulted in hyperechoic streaks extending away from the tube in the direction of the 
transmit pulse propagation. The high droplet concentration (0.3%) increased the number of 
vaporization events, and prevented the presence of gaps in the tube image that were seen at 
the low concentration (0.03%). Gaps result from locations where no droplet vaporization 
was produced, due to the stochastic nature of droplet activation. B-mode images from 
control microbubbles resulted in a sharply defined, hyperechoic tube at 0.3% concentration. 
The TDA technique effectively reduced the signals from microbubbles and the water-
phantom boundary while maintaining the signals from droplets. For 0.03% concentration 
post-TDA, it was possible to obtain a clear image from droplet activation (CTR = 18.1 dB) 
while completely removing the microbubble signals (CTR = 0.4 dB). CTR calculations for 
0.3% concentration at all pressures tested are presented in the last paragraph of the results 
section (see Fig. 6).
The axial resolution in the case of microbubbles was approximately 2 mm, and there was no 
significant effect of the applied pressure (Table II). This value is partially dictated by the 
impulse response of the receive transducer. As the microbubble concentration was reduced, 
the axial resolution deteriorated, but not significantly so (higher values correlate to poorer 
resolution, and vice versa). This result is attributed to a reduction of the signal-to-noise ratio 
degrading the axial resolution measurement at −6 dB. At 700 kPa, the axial resolution in the 
case of droplets at 0.3% and 0.03% concentrations were significantly worse than 
microbubbles at 0.3% concentration. However, the 0.3% concentration of droplets had 
significantly better resolution than the 0.03% concentration of droplets. For the case of 
droplets, the axial resolution is directly linked to the decay rate of the vaporization signal. 
Higher frequency signals (i.e., those produced from smaller droplets/bubbles) decay faster 
and correlate to improved axial resolution.
EP images are shown in Fig. 4. Here, the oscillatory behavior of droplets was integrated and 
projected onto the lateral-elevational plane. This resulted in well-defined boundaries 
between the tube and surrounding tissue phantom. As in the case of B-mode images, the 
high droplet concentration (0.3%) increased the number of vaporization events, and 
prevented the presence of gaps in the tube image that were seen at the low concentration 
(0.03%). Increasing the pressure caused the tube to appear wider (Fig. 5). This can be 
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explained by the fact that at higher applied pressures, activation could be achieved further 
from the tube (see Fig. 7 in section IV). At 450 kPa, the apparent tube width in the case of 
0.3% droplet concentration was 0.67 mm. When taken as a measure of the lateral resolution, 
this was significantly better than when higher pressures were applied to droplets or 
microbubbles at the same concentration (~1.5 mm). There was no significant difference in 
the apparent tube width between droplets at 0.3% and 450 kPa, and droplets at 0.03% and 
640 kPa. This suggests that lowering the concentration raises the threshold for activation 
[43]. It was not possible to generate reliable measures of tube width from microbubbles at 
concentrations of 0.03%, even at the highest pressures tested, as the backscattered signal was 
too weak relative to the tissue signal. Microbubbles at 0.3% and 700 kPa resulted in wider 
tube calculations than noted visually, due to reduced CTR and spreading of the −10 dB 
point.
CTR calculations for B-mode and EP images at 0.3% concentration are shown in Fig. 6. A 
steep increase in CTR occurs when the PNP rises above the threshold pressure for droplet 
activation (between 160 and 450 kPa). Droplet activation is an all-or-nothing phenomenon, 
and increases in pressure well above the threshold result in only slight gains in CTR at the 
expense of reduced lateral resolution. Microbubbles exhibit a more gradual rise in CTR with 
pressure. However, even at the highest achievable acoustic pressure amplitude (700 kPa), the 
CTR from microbubbles was significantly lower than the CTR from droplets. Additionally, 
at 700 kPa, the TDA technique was able to significantly reduce the CTR from microbubbles, 
while having no significant impact on the CTR from droplets. In the B-mode images, the 
variability (error bars) of the CTR from droplets increased at 450 kPa due to the presence of 
signal gaps. When TDA was combined with the EP technique, it was possible to completely 
separate droplet signals from microbubble signals at 0.3% concentration and 640 kPa (CTR 
= 22.68 for droplets and CTR = 0.50 for microbubbles). At lower pressures, no TDA or EP 
was required to separate these signals in the phantom.
IV. Discussion
Here, we demonstrate that droplet activation signals can be detected and extracted from 
microbubble and tissue signals to produce high contrast images. The specificity of the 
approach is based on the detection of the low frequency echo that occurs during droplet 
vaporization (see Fig. 2), which results from the oscillation of generated microbubbles 
around their final resting diameter. The large difference between the activation pulse 
frequency (i.e., 8 MHz) and the listening frequency (i.e., 1 MHz) results in a weak response 
from microbubbles and tissue. Additionally, the receive transducer’s bandwidth (88% at −6 
dB) contributes to signal separation. The microbubble response occurs primarily around the 
excitation frequency and is reduced at 1 MHz, whereas a portion of the droplet vaporization 
signals are emitted directly within the bandwidth of the receive transducer. An advantage of 
imaging droplet vaporization is increased penetration depth, because of the weak attenuation 
of low frequency droplet content in tissue. Additionally, the contrast enhancement of the 
technique is also improved by the absence of non-linear propagation in tissue at the listening 
frequency.
Arena et al. Page 9













Peaks in the droplet spectrum were observed primarily between 400 kHz and 1.6 MHz. 
According to Sheeran et al. [35], this behavior follows the model for a damped harmonic 
oscillator undergoing un-forced oscillation [36]:
(3, 4)
where fM is the natural resonance frequency, δ is the total damping coefficient (0.76), r is the 
radius of the generated microbubbles, κ is the polytropic exponent (1.06), Pl is the ambient 
pressure (101.325 kPa), and ρl is the density of the surrounding liquid (994 kg.cm−3). The 
model predicts that smaller droplets will generate smaller microbubbles that oscillate at 
higher frequencies when compared to larger droplets. Oscillation frequencies (damped) 
ranging from 400 kHz to 1.6 MHz correspond to initial droplet diameters ranging from 2.4 
µm to 600 nm, respectively. According to the droplet characterization results (see Methods 
section), this is only a small proportion of the content present in the microcellulose tube. The 
peak in the droplet distribution occurs at 111 nm, and these droplets would generate 
microbubbles that oscillate at 8.7 MHz.
Several authors have studied vaporization dynamics using high-speed microscopy [23, 43–
45]. Shpak et al. describe three distinct regimes, including droplet deformation, rapid growth 
of vapor bubbles, and slow expansion after ultrasound exposure [45]. When longer pulses (> 
5 cycles) were used, forced oscillations of the generated microbubbles during the rapid 
growth phase were observed, as opposed to the natural response seen here. Doinikov et al. 
has recently developed a comprehensive model to predict the growth of the vapor bubble 
inside a droplet from the induction stage to the oscillatory stage [46]. This model, which is 
the result of the underlying fluid dynamics and thermodynamics, explains additional features 
of droplet activation that were seen experimentally, such as the influence of the 
perfluorocarbon core material. For example, when using decafluorobutane (DFB), which has 
a higher boiling point than OFP, the intensity of the impulse wave that occurs at the onset of 
vaporization is reduced, because the event occurs more slowly. The intensity of the wave 
front is also reduced for smaller droplets, as they displace less fluid upon activation.
B-mode images (Fig. 3, 40 dB dynamic range) were visibly degraded in the axial dimension 
compared to the calculated values for axial resolution at −6 dB (Table II). This is due to the 
greater signal energy present below 6 dB for droplets from generated bubble ringing. 
Improved axial resolution is possible with the detection of smaller droplets (100–200 nm) 
that have a higher frequency vaporization signal that decays more rapidly. Additionally, in 
terms of applications, detection of smaller droplets would improve the systems ability to 
monitor extravasated nanodroplets. In this study, the oscillation frequency of droplets on the 
order of 100 nm overlaps with linear reflections from interrogated media (e.g., microbubbles 
and tissue) and falls far outside the bandwidth of the 1 MHz receive transducer. To view 
these signals, both the transmit and receive frequency would have to be raised, such that the 
receive frequency is centered around the droplet oscillation frequency, and the transmit pulse 
is short enough so as not to influence the oscillation. Nevertheless, a higher transmit 
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frequency (e.g., >20 MHz) may limit the ability to achieve droplet vaporization through a 
depth of tissue. The TDA approach could represent an alternative option for extracting the 
signal from smaller droplets. The efficiency of TDA has already been demonstrated to reject 
clutter during color Doppler imaging [42], and it has been shown here to reduce both the 
microbubble response at 1 MHz.
Small droplet vaporization signals could be easily detected when activation is induced by 
pulsed laser irradiation. Recently, Wilson et al. have investigated the potential of 
perfluorocarbon nanodroplets with encapsulated plasmonic nanoparticles for photoacoustic 
imaging [47]. They reported a substantial increase of the photoacoustic signal during droplet 
activation. We support that this contrast enhancement corresponds to the detection of the 
unique acoustic signature from nanodroplet vaporization. Therefore, this photoacoustic 
signal could be optimized by selecting the listening frequency as close as possible to the 
resonance frequency of the final microbubbles produced after vaporization [35].
One emerging technique for improving the resolution of ultrasound when operating at low-
frequencies relies on the spatial localization of isolated microbubble signals [48–50]. The 
position of a single microbubble is estimated from time-of-flight or center-of-mass 
calculations on received signals, and the position density map for multiple microbubble 
signals can be generated to “paint” out structures wherein the bubbles are confined. This 
method of super-resolution can overcome the diffraction limit of conventional ultrasound 
imaging. A similar approach could be applied to droplet imaging in order to improve the 
axial resolution. The center of mass or peak of the vaporization signal could be used to 
depict its axial position. Further, the energy of the vaporization signal could be correlated to 
pixel intensity, as performed here.
The lateral resolution of the droplet imaging system is dictated by the activation area (Fig. 
7). At higher applied pressures, the area capable of inducing droplet vaporization increases. 
As a result, activation can be achieved further from the tube and the apparent tube width 
increases. To improve the lateral resolution, the activation area should be decreased. This 
could be accomplished through the use of a linear or phased array transducer with a larger 
aperture than the piston transducer employed here to better focus the transmit beam. 
Alternatively, the activation area could be decreased by raising the threshold for droplet 
activation. Less volatile perfluorocarbon gases could be used for the droplet core, or the 
concentration of droplets could be reduced. In either of these cases, longer acquisition 
periods would be required to ensure that a vaporization event was captured at each position 
to prevent the presence of signal gaps in the reconstructed images.
Droplet activation imaging has the potential to be applied in combination with droplet-
mediated therapy or as a stand-alone diagnostic imaging modality. Its utility as a diagnostic 
will depend largely on the safety of the vaporization event. Microscale droplets have been 
shown to promote tissue occlusion [16, 24, 25], and nanoscale droplets have been shown to 
enhance drug delivery [26–28] and tissue ablation [29–32] when long pulses are used to 
induce cavitation of the generated microbubbles. However, little is known about the 
bioeffects associated with nanoscale droplets if short pulses are applied for activation 
without subsequent cavitation. Although maximum expansion of sub-micron droplets is 
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likely less than the diameter of a standard capillary, there remains the possibility of 
bioeffects due to wall velocity or associated fluid shear. Future studies will be needed to 
further elucidate the safety of sub-micron droplet activation in-vivo.
When combined with therapy, droplet imaging has the ability to distinguish newly generated 
microbubbles from microbubbles that were generated from prior activation pulses and 
remain in circulation. For example, during droplet-mediated high-intensity focused 
ultrasound, droplet activation is required to enhance thermal energy deposition. Compared to 
microbubbles, droplets are found to reduce the acoustic energy and time required to cause an 
ablation [18]. By using ultrasound to monitor the vaporization of fresh droplets in real-time, 
it would be possible to visualize and control which areas of the tissue are treated versus 
spared. Furthermore, pressure and temperature play a major role in droplet activation [46]. 
Detection of the vaporization signal could also be useful in determining whether the PNP 
and/or the temperature exceed a threshold in a targeted region during treatment [51].
For diagnostic purposes, it may be possible to deduce information about the surrounding 
environment by examining the droplet vaporization signals. Asami et al. have shown that 
droplet activation behavior is influenced by the viscoelastic properties of a tissue phantom 
(when the droplets are embedded directly in the phantom) [52]. The peak intensity of the 
impulse wave was reduced with increasing tissue stiffness. A system designed to monitor 
this oscillatory behavior could map the tissue stiffness in real-time. In addition to 
viscoelastic properties, shifts in oscillation frequency may correlate to changes in 
temperature and pressure. Microbubbles have been shown to exhibit an increased radial 
excursion at higher temperatures [53] and decreased sub-harmonic response at higher 
ambient pressures [54]. If possible, correlating these changes with vaporization behavior will 
likely require a monodisperse population of droplets [55, 56] with a finely tuned oscillation 
frequency.
The droplet activation detection system was successful at isolating droplet vaporization 
events from pre-existing, or remnant, microbubbles. This is evident from the higher CTRs 
seen in both B-mode and EP images of droplet trials compared to microbubble controls (Fig. 
6). Further, as the time course of droplet signals varied widely between vaporization events 
compared to microbubble signals, the TDA approach enhanced signal separation by 
suppressing microbubble signals while leaving droplet signals largely unchanged. It is 
important to note that the ‘pulse-high, listen-low’ scheme was designed to exclude 
microbubble signals. However, many proven microbubble specific imaging techniques for 
vascular applications, such as pulse inversion [6], amplitude modulation [7], and chirp 
reversal [9] are capable of generating CTRs in the same range as seen here for droplets [57]. 
As droplets continue to gain momentum as theranostic agents, the ability to map their 
conversion to microbubbles in real-time using the dual frequency technique could 
concurrently become an important tool in clinical practice.
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Experimental setup. Confocal piston transducers are triggered to transmit (8 MHz, inner 
element) and receive (1 MHz, outer element) acoustic signals. The location of the 
transducers is rastered in the lateral-elevational plane to image the tissue-mimicking 
phantom.
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(a) Acoustic signals and (b) frequency spectrum from different contrast agents infused 
through the tissue-mimicking phantom. The concentration of droplets and microbubbles was 
0.3%, and the peak negative pressure (PNP) at the focus was 700 kPa. The signals are 
presented following band-pass filtering (400 kHz to 1.6 MHz), and the magnitude is given in 
arbitrary units, a.u.
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B-mode images of various contrast agents infused through the tissue-mimicking phantom. 
Different concentrations are presented before (left) and after (right) time-domain averaging, 
TDA. The pressure at the focus was 700 kPa. At that pressure, it was possible to see linear 
reflections from the water-phantom boundary before TDA. The dynamic range is 40 
decibels, dB. Images were normalized to the 0.3% droplet trial pre-TDA. The red dotted 
areas indicated regions of interest for CTR calculations.
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Energy projection (EP) images of various contrast agents infused through the tissue-
mimicking phantom. Different concentrations and pressures are presented before (left two 
columns) and after (right two columns) time-domain averaging, TDA. The dynamic range is 
30 decibels, dB. Images were normalized to the 0.3%, 700 kPa droplet trial pre-TDA. The 
red dotted areas indicated regions of interest for CTR calculations.
Arena et al. Page 22














Apparent width of the microcellulose tube as a function of contrast agent formulation, 
concentration, and applied pressure. The error bars indicate one standard deviation. The 
brackets indicate that a significant difference is present between groups (p < 0.05).
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Contrast-to-tissue ratio (CTR) for B-mode and energy projection (EP) images as a function 
of contrast agent formulation and applied pressure. The effects of time-domain averaging 
(TDA) are shown by the dotted lines. The contrast agent concentration is 0.3%. The error 
bars indicate one standard deviation. The asterisks denote a significant effect of TDA within 
droplet or microbubble groups (p < 0.05).
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Schematic diagram of energy projection (EP) image creation. The apparent tube width is 
limited by the droplet activation area.
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TABLE II











450 3.86 ± 0.73
640 3.35 ± 1.20#
700 3.28 ± 1.20#
Droplets 0.03%
450 3.65 ± 0.82
640 3.86 ± 0.75*
700 3.56 ± 1.03*
Microbubbles 0.3%
640 2.06 ± 0.12#
700 1.91 ± 0.11#,*
Microbubbles 0.03% 700 3.18 ± 0.47
*
indicates a significant difference from 0.3% droplet concentration at equivalent pressures (p < 0.05).
#
indicates a significant difference from 0.03% droplet concentration at equivalent pressures (p < 0.05).
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